A total of 50 primary prostate cancer and 41 CRPC samples were collected (Table 1) and the data showed that 65% of CRPC patients and only 52% of PPC patients exhibited high levels of K-Ras expression. The gene discussed is KRAS; the disease is prostate carcinoma.